Case Report
Human Immunodeficiency Virus and Leprosy Coinfection: Challenges in Resource-Limited Setups
Table 1
Clinical, immunological, and virological parameters of an HIV-1-leprosy coinfected patient in western Kenya.
| EVENT | Weight (kg) | CD4 count (Cells/mL) | CD4% | Plasma viral load (copies/mL) |
| Enrolment | 65 | 145 | 10 | | ART initiated 1 month later | | | | | 5 months* | 66 | 272 | 16 | | 12 months* | 64 | 154 | 13 | | 15 months* | 65 | 152 | 13 | | 23 months* | 62 | 192 | 11 | | 27 months* | 58 | 110 | 8 | | 29 months* | | | | 1,084,798 | 32 months* | 62 | 169 | 11 | | 35 months * | | | | 433,376 | 40 months* | 60 | 155 | 13 | | 45 months* | 55 | 195 | 7 | | 47 months: Switch to second-line ART | | | | | 6 months** | 60 | 320 | 11 | | 7 months** | Started antileprosy chemotherapy | 13 months** | | | | 188 |
|
|
*After ART initiation.
**After initiation of second-line ART.
|